Wegovy Maker Novo Nordisk to Spend $6 Billion Boosting Production Capacity -- Update

By Dominic Chopping Novo Nordisk, the Danish pharmaceutical giant that makes the blockbuster Wegovy obesity drug, said it will invest more than $6 billion to...

Related Keywords

Funen ,Syddanmark ,Denmark ,Kalundborg ,Sjæand ,Danish ,Novo Nordisk Ozempic ,Novo Nordisk ,Dominic Chopping ,Article Normal ,Pharmaceuticals ,Healthcare Life Sciences ,Output Production ,Capacity Facilities ,Corporate Industrial News ,Products Services ,Political General News ,Society Community ,Diabetes ,Health ,Medical Conditions ,Obesity ,Social Issues ,Synd ,Novob Ko ,Dk Novo B ,Nvo ,Dk0062498333 ,Us6701002056 ,Output ,Production ,Capacity ,Facilities ,Corporate ,Industrial News ,Products ,Services ,Political ,General News ,Society ,Community ,Healthcare ,Life Sciences ,